Enteral feeding composition and necrotizing enterocolitis

Seminars in Fetal and Neonatal Medicine

Volumn 23, Issue 6, 2018, Pages 406-410

  Cruz, Diomel de la ^a   Bazacliu, Catalina ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Donor breast milk; Human milk; Human milk oligosaccharides; Lactoferrin; Necrotizing enterocolitis

Indexed keywords

2' FUCOSYLLACTOSE; ARGININE; GLUTAMINE; HUMAN MILK OLIGOSACCHARIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTOFERRIN; OLIGOSACCHARIDE; PLACEBO; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ARTIFICIAL MILK; BREAST MILK; CHEMOPROPHYLAXIS; COLOSTRUM; DIET SUPPLEMENTATION; DRUG EFFECT; ENTERIC FEEDING; FOOD COMPOSITION; FOOD INTAKE; FORTIFIED FOOD; HUMAN; INCIDENCE; INFANT NUTRITION; NECROTIZING ENTEROCOLITIS; NONHUMAN; PREMATURITY; PROTECTION; REVIEW; RISK REDUCTION; SEPSIS; VERY LOW BIRTH WEIGHT; NEWBORN;

ENTERAL NUTRITION; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MILK, HUMAN;

EID: 85051835050     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2018.08.003     Document Type: Review

References (74)

1. Neu, J., Walker, W.A., Necrotizing enterocolitis. N Engl J Med 364 (2011), 255–264.
2. Horbar, J.D., Carpenter, J.H., Badger, G.J., et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 129 (2012), 1019–1026.
3. Ganapathy, V., Hay, J.W., Kim, J.H., Costs of necrotizing enterocolitis and cost-effectiveness of exclusively human milk-based products in feeding extremely premature infants. Breastfeed Med 7 (2012), 29–37.
4. Ganapathy, V., Hay, J.W., Kim, J.H., Lee, M.L., Rechtman, D.J., Long term healthcare costs of infants who survived neonatal necrotizing enterocolitis: a retrospective longitudinal study among infants enrolled in Texas Medicaid. BMC Pediatr, 13, 2013, 127.
5. Bisquera, J.A., Cooper, T.R., Berseth, C.L., Impact of necrotizing enterocolitis on length of stay and hospital charges in very low birth weight infants. Pediatrics 109 (2002), 423–428.
6. Neu, J., Necrotizing enterocolitis: the mystery goes on. Neonatology 106 (2014), 289–295.
7. Torrazza, R.M., Neu, J., The altered gut microbiome and necrotizing enterocolitis. Clin Perinatol 40 (2013), 93–108.
8. Patole, S., Prevention and treatment of necrotising enterocolitis in preterm neonates. Early Hum Dev 83 (2007), 635–642.
9. Morowitz, M.J., Poroyko, V., Caplan, M., Alverdy, J., Liu, D.C., Redefining the role of intestinal microbes in the pathogenesis of necrotizing enterocolitis. Pediatrics 125 (2010), 777–785.
10. Carlisle, E.M., Morowitz, M.J., The intestinal microbiome and necrotizing enterocolitis. Curr Opin Pediatr 25 (2013), 382–387.
11. Lin, P.W., Stoll, B.J., Necrotising enterocolitis. Lancet 368:9543 (2006), 1271–1283.
12. Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 129 (2012), e827–e841.
13. Bharwani, S.K., Green, B.F., Pezzullo, J.C., Bharwani, S.S., Bharwani, S.S., Dhanireddy, R., Systematic review and meta-analysis of human milk intake and retinopathy of prematurity: a significant update. J Perinatol 36 (2016), 913–920.
14. Patel, A.L., Johnson, T.J., Engstrom, J.L., et al. Impact of early human milk on sepsis and health-care costs in very low birth weight infants. J Perinatol 33 (2013), 514–519.
15. Lechner, B.E., Vohr, B.R., Neurodevelopmental outcomes of preterm infants fed human milk: a systematic review. Clin Perinatol 44 (2017), 69–83.
16. Singhal, A., Cole, T.J., Fewtrell, M., Lucas, A., Breastmilk feeding and lipoprotein profile in adolescents born preterm: follow-up of a prospective randomised study. Lancet 363:9421 (2004), 1571–1578.
17. Singhal, A., Cole, T.J., Lucas, A., Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials. Lancet 357:9254 (2001), 413–419.
18. Isaacs, E.B., Fischl, B.R., Quinn, B.T., Chong, W.K., Gadian, D.G., Lucas, A., Impact of breast milk on intelligence quotient, brain size, and white matter development. Pediatr Res 67 (2010), 357–362.
19. Sullivan, S., Schanler, R.J., Kim, J.H., et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr, 156, 2010 562–567.e1.
20. Cristofalo, E.A., Schanler, R.J., Blanco, C.L., et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr, 163, 2013 1592–5.e1.
21. Schanler, R.J., Lau, C., Hurst, N.M., Smith, E.O., Randomized trial of donor human milk versus preterm formula as substitutes for mothers' own milk in the feeding of extremely premature infants. Pediatrics 116 (2005), 400–406.
22. Meinzen-Derr, J., Poindexter, B., Wrage, L., Morrow, A.L., Stoll, B., Donovan, E.F., Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death. J Perinatol 29 (2009), 57–62.
23. Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 336(8730):1519–1523.
24. Abrams, S.A., Schanler, R.J., Lee, M.L., Rechtman, D.J., Greater mortality and morbidity in extremely preterm infants fed a diet containing cow milk protein products. Breastfeed Med 9 (2014), 281–285.
25. Brown, J.V., Embleton, N.D., Harding, J.E., McGuire, W., Multi-nutrient fortification of human milk for preterm infants. Cochrane Database Syst Rev, 5, 2016 CD000343.
26. Quigley, M., McGuire, W., Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev, 4, 2014 CD002971.
27. Boyd, C.A., Quigley, M.A., Brocklehurst, P., Donor breast milk versus infant formula for preterm infants: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 92 (2007), F169–F175.
28. Corpeleijn, W.E., de Waard, M., Christmann, V., et al. Effect of donor milk on severe infections and mortality in very low-birth-weight infants. JAMA Pediatr, 170, 2016, 654.
29. O'Connor, D.L., Gibbins, S., Kiss, A., et al. Effect of supplemental donor human milk compared with preterm formula on neurodevelopment of very low-birth-weight infants at 18 months. J Am Med Assoc, 316, 2016, 1897.
30. Peila, C., Moro, G.E., Bertino, E., et al. The effect of holder pasteurization on nutrients and biologically-active components in donor human milk: a review. Nutrients, 8(8), 2016.
31. Ewaschuk, J.B., Unger, S., O'Connor, D.L., et al. Effect of pasteurization on selected immune components of donated human breast milk. J Perinatol 31 (2011), 593–598.
32. Corpeleijn, W.E., Kouwenhoven, S.M.P., Paap, M.C., et al. Intake of own mother's milk during the first days of life is associated with decreased morbidity and mortality in very low birth weight infants during the first 60 days of life. Neonatology 102 (2012), 276–281.
33. Wiedmeier, S., Henry, E., Baer, V., et al. Center differences in NEC within one health-care system may depend on feeding protocol. Am J Perinatol 25 (2008), 5–11.
34. Patole, S.K., de Klerk, N., Impact of standardised feeding regimens on incidence of neonatal necrotising enterocolitis: a systematic review and meta-analysis of observational studies. Arch Dis Child Fetal Neonatal Ed 90 (2005), F147–F151.
35. Jasani, B., Patole, S., Standardized feeding regimen for reducing necrotizing enterocolitis in preterm infants: an updated systematic review. J Perinatol 37 (2017), 827–833.
36. Berseth, C.L., Bisquera, J.A., Paje, V.U., Prolonging small feeding volumes early in life decreases the incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 111 (2003), 529–534.
37. Henderson, G., Craig, S., Brocklehurst, P., McGuire, W., Enteral feeding regimens and necrotising enterocolitis in preterm infants: a multicentre case–control study. Arch Dis Child Fetal Neonatal Ed 94 (2009), F120–F123.
38. Leaf, A., Dorling, J., Kempley, S., et al. Early or delayed enteral feeding for preterm growth-restricted infants: a randomized trial. Pediatrics 129 (2012), e1260–e1268.
39. Morgan, J., Young, L., Mcguire, W., Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev, 12, 2014 CD001970.
40. Morgan, J., Young, L., Mcguire, W., Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev, 12, 2014 CD001241.
41. Stoll, B.J., Hansen, N.I., Adams-Chapman, I., et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. J Am Med Assoc, 292, 2004, 2357.
42. Karagol, B.S., Zenciroglu, A., Okumus, N., Polin, R.A., Randomized controlled trial of slow vs rapid enteral feeding advancements on the clinical outcomes of preterm infants with birth weight 750–1250 g. J Parenter Enteral Nutr 37 (2013), 223–228.
43. Ehrenkranz, R.A., Dusick, A.M., Vohr, B.R., Wright, L.L., Wrage, L.A., Poole, W.K., Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics 117 (2006), 1253–1261.
44. Picaud, J.-C., Houeto, N., Buffin, R., Loys, C.-M., Godbert, I., Haÿs, S., Additional protein fortification is necessary in extremely low-birth-weight infants fed human milk. J Pediatr Gastroenterol Nutr 63 (2016), 103–105.
45. Rosas, R., Sanz, M., Fernández-Calle, P., et al. Experimental study showed that adding fortifier and extra-hydrolysed proteins to preterm infant mothers' milk increased osmolality. Acta Paediatr 105 (2016), e555–e560.
46. Shah, S.D., Dereddy, N., Jones, T.L., Dhanireddy, R., Talati, A.J., Early versus delayed human milk fortification in very low birth weight infants – a randomized controlled trial. J Pediatr, 174, 2016 126–31.e1.
47. Mukhopadhyay, K., Narnag, A., Mahajan, R., Effect of human milk fortification in appropriate for gestation and small for gestation preterm babies: a randomized controlled trial. Indian Pediatr 44 (2007), 286–290.
48. Ballard, O., Morrow, A.L., Human milk composition. Pediatr Clin 60 (2013), 49–74.
49. Shen, R.L., Thymann, T., Østergaard, M.V., et al. Early gradual feeding with bovine colostrum improves gut function and NEC resistance relative to infant formula in preterm pigs. Am J Physiol Gastrointest Liver Physiol 309 (2015), G310–G323.
50. Juhl, S.M., Ye, X., Zhou, P., et al. Bovine colostrum for preterm infants in the first days of life. J Pediatr Gastroenterol Nutr 66 (2018), 471–478.
51. Seigel, J.K., Smith, P.B., Ashley, P.L., et al. Early administration of oropharyngeal colostrum to extremely low birth weight infants. Breastfeed Med 8 (2013), 491–495.
52. Romano-Keeler, J., Azcarate-Peril, M.A., Weitkamp, J.-H., et al. Oral colostrum priming shortens hospitalization without changing the immunomicrobial milieu. J Perinatol 37 (2017), 36–41.
53. Glass, K., Greecher, C., Doheny, K., Oropharyngeal administration of colostrum increases salivary secretory IgA levels in very low-birth-weight infants. Am J Perinatol 34 (2017), 1389–1395.
54. Lee, J., Kim, H.-S., Jung, Y.H., et al. Oropharyngeal colostrum administration in extremely premature infants: an RCT. Pediatrics 135 (2015), e357–e366.
55. Actor, J.K., Hwang, S.-A., Kruzel, M.L., Lactoferrin as a natural immune modulator. Curr Pharmaceut Des 15 (2009), 1956–1973.
56. Manzoni, P., Meyer, M., Stolfi, I., et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Hum Dev 90 (2014), S60–S65.
57. Akin, I.M., Atasay, B., Dogu, F., et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. Am J Perinatol 31 (2014), 1111–1120.
58. Pammi, M., Abrams, S.A., Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev, 2, 2015 CD007137.
59. Sherman, M.P., Adamkin, D.H., Niklas, V., et al. Randomized controlled trial of talactoferrin oral solution in preterm infants. J Pediatr, 175, 2016 68–73.e3.
60. Underwood, M.A., Gaerlan, S., De Leoz, M.L.A., et al. Human milk oligosaccharides in premature infants: absorption, excretion and influence on the intestinal microbiota. Pediatr Res 78 (2015), 670–677.
61. Nanthakumar, N.N., Dai, D., Newburg, D.S., Walker, W.A., The role of indigenous microflora in the development of murine intestinal fucosyl- and sialyltransferases. Faseb J 17 (2003), 44–46.
62. Morrow, A.L., Ruiz-Palacios, G.M., Jiang, X., Newburg, D.S., Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 135 (2005), 1304–1307.
63. Jantscher-Krenn, E., Zherebtsov, M., Nissan, C., et al. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats. Gut 61 (2012), 1417–1425.
64. Autran, C.A., Schoterman, M.H.C., Jantscher-Krenn, E., Kamerling, J.P., Bode, L., Sialylated galacto-oligosaccharides and 2′-fucosyllactose reduce necrotising enterocolitis in neonatal rats. Br J Nutr 116 (2016), 294–299.
65. Good, M., Sodhi, C.P., Yamaguchi, Y., et al. The human milk oligosaccharide 2′-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine. Br J Nutr 116 (2016), 1175–1187.
66. He, Y., Liu, S., Leone, S., Newburg, D.S., Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine. Mucosal Immunol 7 (2014), 1326–1339.
67. Morrow, A.L., Meinzen-Derr, J., Huang, P., et al. Fucosyltransferase 2 non-secretor and low secretor status predicts severe outcomes in premature infants. J Pediatr 158 (2011), 745–751.
68. Maheshwari, A., Kelly, D.R., Nicola, T., et al. TGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology 140 (2011), 242–253.
69. Frost, B.L., Jilling, T., Lapin, B., Maheshwari, A., Caplan, M.S., Maternal breast milk transforming growth factor-beta and feeding intolerance in preterm infants. Pediatr Res 76 (2014), 386–393.
70. Foster, J.P., Seth, R., Cole, M.J., Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates. Cochrane Database Syst Rev, 4, 2016 CD001816.
71. van der Hulst, R.R., van Kreel, B.K., von Meyenfeldt, M.F., et al. Glutamine and the preservation of gut integrity. Lancet 341:8857 (1993), 1363–1365.
72. Moe-Byrne, T., Brown, J.V.E., McGuire, W., Glutamine supplementation to prevent morbidity and mortality in preterm infants. Cochrane Database Syst Rev, 1, 2016 CD001457.
73. Becker, R.M., Wu, G., Galanko, J.A., et al. Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr 137 (2000), 785–793.
74. Shah, P.S., Shah, V.S., Kelly, L.E., Arginine supplementation for prevention of necrotising enterocolitis in preterm infants. Cochrane Database Syst Rev, 4, 2017 CD004339.